Recombinant multi-species PDLIM1/CLP36 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDLIM1/CLP36 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the enigma protein family. The protein contains two protein interacting domains, a PDZ domain at the amino terminal end and one to three LIM domains at the carboxyl terminal. It is a cytoplasmic protein associated with the cytoskeleton. The protein may function as an adapter to bring other LIM-interacting proteins to the cytoskeleton. Pseudogenes associated with this gene are located on chromosomes 3, 14 and 17. [provided by RefSeq, Oct 2012]
The Alternative Names of target: C-terminal LIM domain protein 1,CLIM1,CLP-36,CLP36,Clim1,Elfin,HEL-S-112,LIM domain protein CLP-36,PDLIM1,PDZ and LIM domain protein 1,Pdlim1,hCLIM1,mClim1

Target products collectionGo to PDLIM1/CLP36 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2649-Ag-1/ GM-Tg-hg-IP2649-Ag-2 Human PDLIM1/CLP36 protein Human
GM-Tg-rg-IP2649-Ag-1/ GM-Tg-rg-IP2649-Ag-2 Rat PDLIM1/CLP36 protein Rat
GM-Tg-mg-IP2649-Ag-1/ GM-Tg-mg-IP2649-Ag-2 Mouse PDLIM1/CLP36 protein Mouse
GM-Tg-cynog-IP2649-Ag-1/ GM-Tg-cynog-IP2649-Ag-2 Cynomolgus/Rhesus macaque PDLIM1/CLP36 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2649-Ag-1/ GM-Tg-felg-IP2649-Ag-2 Feline PDLIM1/CLP36 protein Feline
GM-Tg-cang-IP2649-Ag-1/ GM-Tg-cang-IP2649-Ag-2 Canine PDLIM1/CLP36 protein Canine
GM-Tg-bovg-IP2649-Ag-1/ GM-Tg-bovg-IP2649-Ag-2 Bovine PDLIM1/CLP36 protein Bovine
GM-Tg-equg-IP2649-Ag-1/ GM-Tg-equg-IP2649-Ag-2 Equine PDLIM1/CLP36 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2649-Ag-1/ GM-Tg-hg-IP2649-Ag-2; GM-Tg-rg-IP2649-Ag-1/ GM-Tg-rg-IP2649-Ag-2;
GM-Tg-mg-IP2649-Ag-1/ GM-Tg-mg-IP2649-Ag-2; GM-Tg-cynog-IP2649-Ag-1/ GM-Tg-cynog-IP2649-Ag-2;
GM-Tg-felg-IP2649-Ag-1/ GM-Tg-felg-IP2649-Ag-2; GM-Tg-cang-IP2649-Ag-1/ GM-Tg-cang-IP2649-Ag-2;
GM-Tg-bovg-IP2649-Ag-1/ GM-Tg-bovg-IP2649-Ag-2; GM-Tg-equg-IP2649-Ag-1/ GM-Tg-equg-IP2649-Ag-2
Products Name PDLIM1/CLP36 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PDLIM1/CLP36
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDLIM1/CLP36 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.